Skip to main content
. 2020 May 14;7(4):1664–1675. doi: 10.1002/ehf2.12722

Table 2.

Echocardiographic indices of the study population by the median value of IGFBP7

Echocardiographic indices IGFBP7 < median (N = 135) IGFBP7 ≥ median (N = 136) P value
Left ventricle
Posterior wall thickness (mm) * 10 (8–11.5) 10 (9–12) 0.04
LV mass index (male, g/m2) a 85.4 (67.9–106.2) 111.6 (92.2–130.2) <0.001
LV mass index (female, g/m2) a 77.9 (64.3–97.1) 96.6(81.5–111.6) 0.003
LVEDVi (mL/m2) a 53.3 (44.9–65.7) 68.1 (51.2–86.5) <0.001
LVESVi (mL/m2) a 20.3 (15.3–28.7) 35.5 (18.3–56.3) <0.001
LVEF (%) a 61.6 (51.9–69.2) 50 (30.4–64.7) <0.001
LVEF

<0.001

LVEF a 61.6 (51.9–69.2) 50 (30.4–64.7)
LVEF < 50 (%) 21 (25/117) 48 (53/110)
LVEF ≥ 50 (%) 79 (92/117) 52 (57/110)
Right ventricle
RV diastolic area (cm2) a 19 (14.8–23.4) 22.3 (18.6–27.4) 0.001
RV systolic area (cm2) a 10.4 (8.1–13.9) 14.5 (10.6–18.6) <0.001
RV fractional area change (%) a 43.2 (36.8–51.3) 36.3 (28.1–45.9) <0.001
Right ventricular hypokinesis 0.003
None (%) 85.6 (107/125) 64.6 (73/113)
Mild (%) 5.6 (7/125) 15 (17/113)
Moderate (%) 4.8 (6/125) 11.5 (13/113)
Severe (%) 4 (5/125) 8.6 (10/113)
LAVi (mL/m2) a 28.9 (21.9–36.2) 41.9 (33.1–51.2) <0.001
Trans‐mitral Doppler
E (cm/s) a 72 (61–92) 97.5 (80–121) <0.001
A (cm/s) a 67 (55–85) 65.5 (46–87) 0.45
E/A* 1.04 (0.8–1.3) 1.3 (0.9–1.9) <0.001
DT (ms) a 177 (145–210.5) 167 (129.4–199) 0.04
Pulmonary vein flow
S (cm/s) a 45 (38–57) 35.5 (24–47.5) 0.001
D (cm/s) a 43 (32–52) 55.5 (42.5–68.5) <0.001
S/D a 1.1 (0.8–1.4) 0.6 (0.5–0.9) <0.001
Tissue Doppler
Mitral annular e′ septal (cm/s) a 7 (6–9) 6 (5–7) <0.001
Mitral annular e′ lateral (cm/s) a 9 (6–11) 8 (6–10) 0.09
Mean mitral annular e′ (cm/s) a 8 (6–10) 7 (5.2–9) 0.01
E/e′ a 9.4 (7.4–13.6) 13.4 (10.7–19.6) <0.001
E/e′  15 (%) 19.6 (23/117) 42.5 (46/108) <0.001
Grades of diastolic dysfunction <0.001
Normal (%) 59 (65/110) 19.8 (18/91)
Grade I (%) 15.4 (17/110) 11 (10/91)
Grade II (%) 18.1 (20/110) 36.2 (33/91)
Grade III (%) 6.4 (7/110) 32.9 (30/91)
Indeterminate (%) 0.9 (1/110) 0 (0/91)
TR severity 0.001
None (%) 2.4 (3/127) 2.3 (3/130)
Trace (%) 61.4 (78/127) 40 (52/130)
Mild (%) 28.3 (36/127) 33 (43/130)
Moderate (%) 7.9 (10/127) 21.5 (28/130)
Severe (%) 0 (0/127) 3 (4/130)
MR severity <0.001
None (%) 11.8 (15/127) 3.1 (4/129)
Trace (%) 59 (75/127) 36.4 (47/129)
Mild (%) 19.7 (25/127) 40.3 (52/129)
Moderate (%) 7.9 (10/127) 17 (22/129)
Severe (%) 1.6 (2/127) 3.1 (4/129)

IQR, interquartile range; LV, left ventricle; LVEDVi, left ventricular end‐diastolic volume index; LVESVi, left ventricular end‐systolic volume index; LVEF, left ventricular ejection fraction; RV, right ventricle; LAVi, left atrial volume index; E, early transmitral diastolic velocities; A, late transmitral diastolic velocities; E/A, the ratio of early to late transmitral diastolic velocities; DT, early deceleration time; S, pulmonary venous systolic velocities; D, pulmonary venous diastolic velocities; S/D, the ratio of pulmonary venous systolic to diastolic velocities; E/e′, the ratio between early mitral inflow velocity and mitral annular early diastolic velocity; TR, tricuspid regurgitation; MR, mitral regurgitation; IGFBP7, insulin‐like growth factor binding protein‐7.

Study participants with an IGFBP7 ≥ 119 ng/mL had prevalent cardiac abnormalities.

a

Median and IQR are presented.